136 related articles for article (PubMed ID: 7953986)
1. Carboxyterminal propeptide of type I procollagen in osteomalacia.
Li F; Iqbal J; Wassif W; Kaddam I; Moniz C
Calcif Tissue Int; 1994 Aug; 55(2):90-3. PubMed ID: 7953986
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of bone-specific alkaline phosphatase and procollagen type I carboxyterminal peptide in vitamin D deficiency.
Nawawi H; Girgis SI
Southeast Asian J Trop Med Public Health; 2002; 33 Suppl 2():124-30. PubMed ID: 12755282
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of biochemical markers in patients with metabolic bone disorders.
Hoshino H; Kushida K; Takahashi M; Kawana K; Denda M; Yamazaki K; Inoue T
Endocr Res; 1998 Feb; 24(1):55-64. PubMed ID: 9553754
[TBL] [Abstract][Full Text] [Related]
4. Bone turnover in children with vitamin D deficiency rickets before and during treatment.
Baroncelli GI; Bertelloni S; Ceccarelli C; Amato V; Saggese G
Acta Paediatr; 2000 May; 89(5):513-8. PubMed ID: 10852183
[TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer.
Akimoto S; Akakura K; Shimazaki J
Jpn J Clin Oncol; 1996 Jun; 26(3):157-63. PubMed ID: 8656556
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of procollagen type I carboxyterminal extension peptide in cancer patients with bone metastases.
Santi I; Monti M; Viganò A; D'Aprile E; Rampoldi E; Castellani L; Accinni R; Cunietti E
Int J Biol Markers; 1995; 10(2):107-12. PubMed ID: 7561234
[TBL] [Abstract][Full Text] [Related]
7. Assessment of bone formation by biochemical markers in metabolic bone disease: separation between osteoblastic activity at the cell and tissue level.
Charles P; Hasling C; Risteli L; Risteli J; Mosekilde L; Eriksen EF
Calcif Tissue Int; 1992 Dec; 51(6):406-11. PubMed ID: 1451006
[TBL] [Abstract][Full Text] [Related]
8. [Studies of type I collagen related substances as bone metastatic markers of prostate carcinoma with special regard to serum carboxyterminal propeptide of type. I. Procollagen (PICP), cross-linked carboxyterminal telopeptide of type I collagen (ICTP) and Urinary deoxypyridinoline levels].
Imai T; Honda M; Maeda S; Hosoya Y; Arai T; Sumi S; Umeda H; Yano M; Koga F; Arai K; Yoshida K
Nihon Hinyokika Gakkai Zasshi; 1998 Apr; 89(4):484-91. PubMed ID: 9597867
[TBL] [Abstract][Full Text] [Related]
9. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
Katagiri M; Fukunaga M; Ohtawa T; Harada T
World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
[TBL] [Abstract][Full Text] [Related]
10. Procollagen type I carboxy-terminal propeptide as a marker of osteoblastic bone metastases.
Francini G; Gonnelli S; Petrioli R; Bruni S; Marsili S; Aquino A; Camporeale A
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):125-9. PubMed ID: 8467247
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
López Gavilanes E; González Parra E; de la Piedra C; Caramelo C; Rapado A
Miner Electrolyte Metab; 1994; 20(5):259-64. PubMed ID: 7700213
[TBL] [Abstract][Full Text] [Related]
12. Increased serum levels of carboxyterminal propeptide of type 1 collagen (PICP) in hyperthyroidism.
Legovini P; De Menis E; Da Rin G; Roiter I; Breda F; Artuso V; Di Virgilio R; Conte N
Horm Metab Res; 1994 Jul; 26(7):334-7. PubMed ID: 7959610
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of bone markers in hypophosphatemic rickets/osteomalacia.
Nagata Y; Imanishi Y; Ishii A; Kurajoh M; Motoyama K; Morioka T; Naka H; Mori K; Miki T; Emoto M; Inaba M
Endocrine; 2011 Oct; 40(2):315-7. PubMed ID: 21822687
[TBL] [Abstract][Full Text] [Related]
14. Serum type I procollagen peptide: a non-invasive index of bone formation in patients on haemodialysis?
Hamdy NA; Risteli J; Risteli L; Harris S; Beneton MN; Brown CB; Kanis JA
Nephrol Dial Transplant; 1994; 9(5):511-6. PubMed ID: 8090331
[TBL] [Abstract][Full Text] [Related]
15. Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases.
Ebeling PR; Peterson JM; Riggs BL
J Bone Miner Res; 1992 Nov; 7(11):1243-50. PubMed ID: 1466250
[TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of carboxyterminal propeptide of type 1 procollogen and tissue inhibitor of metalloproteinase 1 in patients with dermatomyositis.
Kubo M; Kikuchi K; Fujimoto M; Tamaki K
Arch Dermatol Res; 1998 May; 290(5):253-7. PubMed ID: 9681676
[TBL] [Abstract][Full Text] [Related]
17. Early predisposition to osteomalacia in Indian adults on phenytoin or valproate monotherapy and effective prophylaxis by simultaneous supplementation with calcium and 25-hydroxy vitamin D at recommended daily allowance dosage: a prospective study.
Krishnamoorthy G; Nair R; Sundar U; Kini P; Shrivastava M
Neurol India; 2010; 58(2):213-9. PubMed ID: 20508338
[TBL] [Abstract][Full Text] [Related]
18. Interrelationship between bone turnover markers and dietary calcium intake in pregnant women: a longitudinal study.
Zeni SN; Ortela Soler CR; Lazzari A; López L; Suarez M; Di Gregorio S; Somoza JI; de Portela ML
Bone; 2003 Oct; 33(4):606-13. PubMed ID: 14555265
[TBL] [Abstract][Full Text] [Related]
19. Changes in bone turnover after parathyroidectomy in dialysis patients: role of calcitriol administration.
Mazzaferro S; Chicca S; Pasquali M; Zaraca F; Ballanti P; Taggi F; Coen G; Cinotti GA; Carboni M
Nephrol Dial Transplant; 2000 Jun; 15(6):877-82. PubMed ID: 10831645
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of bone Gla protein (osteocalcin, BGP) and carboxyterminal propeptide of type I procollagen (PICP) in acromegaly: effects of long-term octreotide treatment.
Terzolo M; Piovesan A; Osella G; Pia A; Reimondo G; Pozzi C; Raucci C; Torta M; Paccotti P; Angeli A
Calcif Tissue Int; 1993 Mar; 52(3):188-91. PubMed ID: 8481830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
